{
  "ticker": "AFP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965836",
  "id": "02965836",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250704",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3d4pnlp9vn.pdf",
  "summary": "### Summary of Material Information:  \n\n- **Director's Share Purchase**:  \n  - **Director**: Hartley Atkinson  \n  - **Transaction**: On-market purchase of **200,000 ordinary shares** in AFT Pharmaceuticals at an **average price of $2.83/share** (total ~**$566,000 NZD**).  \n  - **Dates of Purchase**: June 30, July 1, and July 2, 2025.  \n  - **Total Holdings Post-Transaction**:  \n    - **Atkinson Family Trust**: 72,259,496 shares (previously 72,059,496).  \n    - **Personal Holdings**: 867,826 shares (jointly held as beneficial owner).  \n  - **No Closed Period Trading**: No breach of trading restrictions.  \n\n**No other material capital markets or trading impacts identified.**",
  "usage": {
    "prompt_tokens": 1406,
    "completion_tokens": 177,
    "total_tokens": 1583,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T21:53:42.955181"
}